On March 26, a national day to speak out against AAPI hate, Research!America stands strongly with the Asian-American and Pacific Islander (AAPI) community to #StopAsianHate. Racism and violence have no place in our society. This is, once again, a time for us all to recommit to community. It’s also a time for listening and reflecting. See the resources below from Carnegie Mellon, University of Pittsburgh, and San Francisco State for ways to get involved. Resources Collaboratory Against Hate - Research and Action Center - Led by Carnegie Mellon University and the University of Pittsburgh the center will bring together the collective expertise to better understand and combat hatred based on...
Dear Research Advocate, Advocacy Then and Now: This letter marks #500 since I began this weekly conversation with you. In the first letter, I spoke out against the Budget Control Act and the severe funding caps it would (and did) impose on strategic imperatives like research. You joined with us to help secure modifications to those budget caps to enable funding increases for NIH and other research agencies. Advocacy works. Now, hundreds of letters later, the FY22 budget cycle is about to begin: reports are that President Biden will release the first details of his FY22 budget request next week, to be followed by a more detailed budget later this spring. It was heartening to hear the...
During Women’s History Month, there have been ample opportunities to recognize the work of female pioneers in science. Of course, not long ago, the idea of a woman scientist was a rarity rather than an ordinary reality. At the time that Rosalind Franklin helped discover the structure, and therefore the function, of DNA in 1953, women’s contributions were often dismissed, and Franklin herself received only passing acknowledgment in the seminal double helix paper. Sputnik and the Cold War ushered in a new era of scientific zeal, and more women began to enter science, technology, engineering, and mathematics (STEM) fields. Even so, the entry of women into science-based careers didn’t happen...
*This piece reflects the opinions of the author. For just over a year now, an invisible, deadly enemy has wreaked havoc around the world. Declared a pandemic by the World Health Organization (WHO) in March of 2020, COVID-19 has killed millions, devastated communities, and ravaged the economy. This microscopic enemy, in the form of a virus, has infected nearly 29 million people in the U.S. and claimed the lives of over 520,000 Americans — a number that surpasses combat fatalities in the Vietnam War. As this piece is being written, the U.S. leads the globe in COVID-19 cases, hospitalizations, and deaths. Given the alarming mortality rate and markedly high plateau in COVID-19 infections (50,...
Dear Research Advocate, The Senate HELP Committee and House Energy and Commerce Committee held hearings this week to review the Biden Administration’s pandemic response and ongoing COVID-19 vaccine distribution with CDC Director Dr. Rochelle Walensky, NIH NIAID Director Dr. Anthony Fauci, HHS Chief Scientific Officer for the COVID Response Dr. David Kessler, and FDA CBER Director Dr. Peter Marks. In their testimonies, the Administration officials underscored how utilizing past scientific discoveries in combination with new partnerships led to the development of COVID-19 vaccines and therapeutics at a record pace. They also spoke to concerns regarding equitable vaccine distribution, and how...
Dear Research Advocate, Never Again: One year ago today, the WHO officially declared COVID-19 a pandemic. Within days, statewide stay-at-home orders began across the U.S., and the road before us became frighteningly uncertain. Across the country, COVID-19 has taken almost 530,000 lives; globally, more than 2.6 million have died. Over the course of a year filled with determination, turmoil, and tragedy, the significance of science and technology became crystal clear. Because of decades of basic research, rapid response science & technology (S&T), and heroic public health efforts by individuals laser-focused on saving lives, we have three safe and effective vaccines, and, as new CDC...
Previously, Research!America published a blog post on the science behind mRNA vaccines . With the approval of a third COVID-19 vaccine in the U.S., this one using a different vaccine technology, this blog post will share the science of adenovirus vector vaccines . How does the J&J vaccine work? Is it similar to the Pfizer/BioNTech and Moderna vaccines? The Johnson & Johnson vaccine is an “adenovirus vector” vaccine. Similar to the mRNA vaccines from Pfizer/BioNTech and Moderna, this type of vaccine uses a snippet of genetic material to elicit an immune response, but it uses a different delivery method. Adenovirus vector vaccines use modified cold viruses to deliver genetic material...
Dear Research Advocate, Women in Science and Technology : March is Women’s History Month. The impact of COVID-19 on the careers of women in STEMM is the focus of a report to be released by the National Academies of Science, Engineering, and Medicine (NASEM) on March 9, 2021. How did the COVID-19 pandemic disrupt the careers of women in academic STEMM during 2020 and how might these disruptions—both positive and negative—shape future progress for women in academic STEMM? The public is invited to a discussion with NASEM committee members Eve J. Higginbotham, University of Pennsylvania; Reshma Jagsi, University of Michigan; and Erick C. Jones, University of Texas at Arlington. Register here ...
A recent Research!America blog post discussed the issue of vaccine hesitancy as an obstacle to ensuring that enough U.S. residents receive a COVID-19 vaccine. However, vaccine hesitancy is far from the only barrier to achieving equitable vaccine distribution. Although recent surveys show that historically mistreated groups are somewhat less willing to take the vaccine, a majority of Americans across all racial and ethnic groups say they would take the vaccine if it were available to them today. In spite of this, white Americans are being vaccinated at far higher rates than Americans in other racial groups – rates that reflect more than just vaccine hesitancy. According to the most recent...

Sidebar Quote

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana